• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Predictive and prognostic significance of tumor-infiltrating lymphocytes in high-grade breast cancer

Research Project

Project/Area Number 22501039
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Tumor diagnosis
Research InstitutionNational Cancer Center Japan

Principal Investigator

TSUDA Hitoshi  独立行政法人国立がん研究センター, 中央病院, 科長 (70217321)

Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Keywords乳癌 / 腫瘍浸潤リンパ球 / 治療効果予測 / 組織型 / 薬効評価と予測 / トリプルネガティブ乳癌
Research Abstract

The purpose of the present study was to identify histological surrogate predictive markers of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC). 92 core needle biopsy (CNB) specimens obtained before NAC were available. As controls, CNB specimens from 42 tumors of the hormone receptor-negative and HER2-positive (HR-/HER2+) subtype and 46 tumors of the hormone receptor-positive and HER2-negative (HR+/HER2-) subtype were also included. Histopathological examination including tumor-infiltrating lymphocytes (TIL) and tumor cell apoptosis, and immunohistochemical studies for basal markers were performed, In TNBC, the pCR rate of tumors showing a high TIL score was 37%, and significantly higher than that of the tumors showing a low TIL score (16%, p = 0.05). In a total of 180 breast cancers, the pCR rate of the tumors showing a high TIL score (34%) was significantly higher than that of the tumors showing a low TIL score (10%) (p = 0.0001). In TNBC, the pCR rate of tumors showing an apoptosis score 2 was 48%, and tended to be higher than that of the tumors showing an apoptosis score of 0 or 1 (23%, p = 0.10). In a total of 180 breast cancers, the pCR rate of the tumors showing an apoptosis score 2 (35%) was significantly higher than that of the tumors showing an apoptosis score of 0 or 1 (19%) (p = 0.04). The basal-like marker expression or p53 nuclear immunoreaction was not correlated with pCR in TNBC. Histologically, medullary/atypical medullary and apocrine types showed higher pCR rates (39% and 40%), while central acellular and metaplastic types showed lower pCR rates (21% and 17%). The degree of TIL correlated with immune response appear to play a substantial role in the response to NAC in TNBC.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (30 results)

All 2015 2013 2012 2011 2010 Other

All Journal Article (15 results) (of which Peer Reviewed: 14 results) Presentation (13 results) (of which Invited: 1 results) Book (2 results)

  • [Journal Article] Prognostic impact of Ki-67 labeling indices with three different cut-off values and histological and nuclear grades in hormone-receptor- positive, HER2-negative, node-negative invasive breast cancers.2015

    • Author(s)
      Makiko Ono, Hitoshi Tsuda, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Masashi Ando, Kenji Tamura, Takayuki Kinoshita, Yasuhiro Fujiwara
    • Journal Title

      Breast Cancer

      Volume: (in press) Issue: 2 Pages: 141-152

    • DOI

      10.1007/s12282-013-0464-4

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Prognostic factors for triple- negative breast cancer patients receiving preoperative systemic chemotherapy.2013

    • Author(s)
      Sota Asaga, Takayuki Kinoshita, Takashi Hojo, Junko Suzuki, Kenjiro Jimbo, Hitoshi Tsuda
    • Journal Title

      Clinical Breast Cancer

      Volume: 13巻1号 Pages: 40-46

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers2013

    • Author(s)
      Hitoshi Tsuda (Makiko Ono)
    • Journal Title

      Breast Cancer

      Volume: 20

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prognostic factors for triple-negative breast cancer patients receiving preoperative systemic chemotherapy2013

    • Author(s)
      Hitoshi Tsuda (Sota Asaga)
    • Journal Title

      Clinical Breast Cancer

      Volume: 13(1) Issue: 1 Pages: 40-46

    • DOI

      10.1016/j.clbc.2012.09.013

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The difference in the histologic types of the breast cancer and the response to primary systemic chemotherapy: clinicopathological characteristics and relation with outcome.2012

    • Author(s)
      Tomoya Nagao, Takayuki Kinoshita, Takashi Hojo, Hitoshi Tsuda, Kenji Tamura, Yasuhiro Fujiwara
    • Journal Title

      Breast

      Volume: 21巻3号 Pages: 289-295

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Tumor-infiltrating lymphocytes (TIL) are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.2012

    • Author(s)
      Makiko Ono, Hitoshi Tsuda, Chikako Shimizu, Sohei Yamamoto, Tatsuhiro Shibata, Harukaze Yamamoto, Taizo Hirata, Kan Yonemori, Tsutomu Kouno, Masashi Ando, Kenji Tamura, Noriyuki Katsumata, Takayuki Kinoshita, Yasuhiro Fujiwara
    • Journal Title

      Breast Cancer Research and Treatment

      Volume: 132巻3号 Pages: 793-805

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Expression pattern of stromal cell-derived factor-1 (SDF-1) chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.2012

    • Author(s)
      Takayuki Kobayashi, Hitoshi Tsuda, Tomoyuki Moriya, Tamio Yamasaki, Ryoko Kikuchi, Shigeto Ueda, Junji Yamamoto, Osamu Matsubara
    • Journal Title

      Breast Cancer Research and Treatment

      Volume: 123巻3号 Pages: 733-745

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Tumor-infiltrating lymphocytes are correlated with response to noadjuvant chemotherapy in triple-negative breast cancer2012

    • Author(s)
      Makiko Ono, Hitoshi Tsuda, et al
    • Journal Title

      Breast Cancer Research and Treatment

      Volume: 132(3) Issue: 3 Pages: 793-805

    • DOI

      10.1007/s10549-011-1554-7

    • Related Report
      2012 Annual Research Report 2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics2012

    • Author(s)
      Hitoshi Tsuda (Tomoya Nagao)
    • Journal Title

      Breast

      Volume: 21(3) Issue: 3 Pages: 289-295

    • DOI

      10.1016/j.breast.2011.12.011

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Loss of heterozygosity on chromosome 16q suggests malignancy in coreneedle biopsy specimens of intraductal papillary breast lesions2012

    • Author(s)
      Miwa Yoshida, Hitoshi Tsuda, et al
    • Journal Title

      Virchows Archiv

      Volume: 460(5) Issue: 5 Pages: 497-504

    • DOI

      10.1007/s00428-012-1200-8

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 乳癌:HER2とトリプルネガティブ2012

    • Author(s)
      小倉拓也、津田均
    • Journal Title

      最新医学

      Volume: 67(3) Pages: 364-373

    • Related Report
      2011 Annual Research Report
  • [Journal Article] Early reduction in standardized uptake value after one cycle of neoadjuvant chemo- therapy measured by sequential DG PET/CT is an independent predictor of patho- logical response of primary breast cancer.2010

    • Author(s)
      Shigeto Ueda, Hitoshi Tsuda, Toshiaki Saeki, Kazuhiko Fukatsu, Akihiko Osaki, Takashi Shigekawa, Jiro Ishida, Katsumi Tamura, Yoshiyuki Abe, Jiro Omata, Tomoyuki Moriya, Junji Yamamoto
    • Journal Title

      Breast Journal

      Volume: 16巻6号 Pages: 660-662

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Expression pattern of stromal cell-derived factor-1 (SDF-1) chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.2010

    • Author(s)
      Takayuki Kobayashi, Hitoshi Tsuda, et al.
    • Journal Title

      Breast Cancer Research and Treatment

      Volume: 123(3) Pages: 733-745

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Evaluation of tumor-infiltrating lymphocytes (TIL) and tumor cell apoptosis as predictive markers for response to neoadjuvant chemotherapy in triple-negative breast cancer.

    • Author(s)
      Makiko Ono, Hitoshi Tsuda, et al.
    • Journal Title

      Breast Cancer Research and Treatment

      Volume: In press

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Synchronous unilateral triple breast cancers composed of invasive ductal carcinoma, invasive lobular carcinoma, and Paget's disease : report of a case.

    • Author(s)
      Shunsuke Onoe, Hitoshi Tsuda, et al.
    • Journal Title

      Breast Cancer

      Volume: In press

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Presentation] Intrinsic subtype分類の病理学的考え方(Histological significance of intrinsic subtype classification).2012

    • Author(s)
      津田 均
    • Organizer
      第10回日本臨床腫瘍学会学術集会、国内合同シンポジウ
    • Place of Presentation
      大阪
    • Year and Date
      2012-07-26
    • Related Report
      2012 Final Research Report
  • [Presentation] 乳癌紡錘細胞癌の病理学的リスク因子の検討2012

    • Author(s)
      神谷有希子、吉田正行、麻賀創太、神保健二郎、鈴木純子、北條隆、木下貴之、津田均
    • Organizer
      第20回日本乳癌学会学術総会
    • Place of Presentation
      熊本
    • Related Report
      2012 Annual Research Report 2012 Final Research Report
  • [Presentation] Intrinsic subtype分類の病理学的考え方(Histological significance of intrinsic subtype classification)2012

    • Author(s)
      津田 均
    • Organizer
      第10回日本臨床腫瘍学会学術集会、国内合同シンポジウム
    • Place of Presentation
      大阪
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] 教育講演1.術前術後補助薬物療法の選択に役立つ病理の知識2011

    • Author(s)
      津田均
    • Organizer
      第8回日本乳癌学会関東地方会
    • Place of Presentation
      さいたま(招待講演)
    • Year and Date
      2011-12-03
    • Related Report
      2011 Annual Research Report
  • [Presentation] リンパ節転移陰性luminal乳癌の予後について2011

    • Author(s)
      小野麻紀子、津田均、清水千佳子、温泉川真由、米盛勧、安藤正志、田村研治、勝俣範之、木下貴之、藤原康弘
    • Organizer
      19回日本乳癌学会学術総会
    • Place of Presentation
      仙台
    • Related Report
      2012 Final Research Report
  • [Presentation] Long-term prognostic factors of node-negative invasive breast cancer of luminal subtype: A comparison between histological grades and molecular markers including. Ki67 and HER22011

    • Author(s)
      Ono Makiko, Hitoshi Tsuda, Chikako Shimizu, Mayu Yunokawa, Kan Yonemori, Masashi Ando, Kenji Tamura, Noriyuki Katsumata, Takayuki Kinoshita, Yasuhiro Fujiwara
    • Organizer
      第9回日本臨床腫瘍学会学術集会
    • Place of Presentation
      横浜
    • Related Report
      2012 Final Research Report
  • [Presentation] リンパ節転移陰性luminal乳癌の予後について2011

    • Author(s)
      小野麻紀子、津田均, 他
    • Organizer
      第19回日本乳癌学会学術総会
    • Place of Presentation
      仙台
    • Related Report
      2011 Annual Research Report
  • [Presentation] Hierarchical clustering analysis of array CGH data identifies clinicopathologically distinct groups of lymph-node-negative in vasive breast cancer2011

    • Author(s)
      Ryoko Kikuchi, Hitoshi Tsuda, et al
    • Organizer
      102^<nd> Annual Meeting of American Association for Cancer Research
    • Place of Presentation
      Orlando, TX, U.S.A
    • Related Report
      2011 Annual Research Report
  • [Presentation] トリプルネガティブ乳癌(TNBC)における病理学的治療効果予測因子2010

    • Author(s)
      小野麻紀子、津田均、清水千佳子、平岡伸介、田村研治、山本春風、米盛勧、安藤正志、勝俣範之、木下貴之、藤原康弘
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪
    • Related Report
      2012 Final Research Report
  • [Presentation] トリプルネガティブ乳癌(TNBC) における病理学的治療効果予測因子:組織亜型と腫瘍浸潤リンパ球(TIL)2010

    • Author(s)
      小野麻紀子、津田均、清水千佳子、平岡伸介、田村研治、山本春風、平田泰三、米盛勧、河野勤、安藤正志、勝俣範之、木下貴之、藤原康弘
    • Organizer
      第18回日本乳癌学会学術総会
    • Place of Presentation
      札幌
    • Related Report
      2012 Final Research Report
  • [Presentation] トリプルネガティブ乳癌(TNBC)における病理学的治療効果予測因子:組織亜型と腫瘍浸潤リンパ球(TIL)2010

    • Author(s)
      小野麻紀子、津田均, 他
    • Organizer
      第18回日本乳癌学会学術総会
    • Place of Presentation
      札幌市
    • Related Report
      2010 Annual Research Report
  • [Presentation] シンポジウム 乳がん個別化治療のための病理診断および分子病理診断2010

    • Author(s)
      津田均, 他
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪市
    • Related Report
      2010 Annual Research Report
  • [Presentation] トリプルネガティブ乳癌(TNBC)における病理学的治療効果予測因子2010

    • Author(s)
      小野麻紀子、津田均, 他
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪市
    • Related Report
      2010 Annual Research Report
  • [Book] Tubular carcinoma and cribriform carcinoma, WHO Classification of Tumours of the Breast. 4th ed.2012

    • Author(s)
      Hitoshi Tsuda (Emad Rakha)
    • Total Pages
      240
    • Publisher
      World Health Organization. International Agency for Research on Cancer, Lyon
    • Related Report
      2012 Annual Research Report
  • [Book] Inflammatory carcinoma, WHO Classification of Tumours of the Breast. 4th ed.2012

    • Author(s)
      Hitoshi Tsuda (Emmanuelle Charafe-Jauffret)
    • Total Pages
      240
    • Publisher
      World Health Organization. International Agency for Research on Cancer. Lyon
    • Related Report
      2012 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi